Non-alcoholic fatty liver diseases: from role of gut microbiota to microbial-based therapies-Reference-Cited by-同舟云学术

Non-alcoholic fatty liver diseases: from role of gut microbiota to microbial-based therapies

Published:2019-12-11 Issue:4 Volume:39 Page:613-627
ISSN:0934-9723
Container-title:European Journal of Clinical Microbiology & Infectious Diseases
language:en
Short-container-title:Eur J Clin Microbiol Infect Dis

Author:

Ebrahimzadeh Leylabadlo Hamed,Ghotaslou Reza^ORCID,Samadi Kafil Hossein,Feizabadi Mohammad Mehdi,Moaddab Seyed Yaghoub,Farajnia Safar,Sheykhsaran Elham,Sanaie Sarvin,Shanehbandi Dariush,Bannazadeh Baghi Hossein

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10096-019-03746-1.pdf

Reference128 articles.

1. Sender R, Fuchs S, Milo R (2016) Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans. Cell 164(3):337–340

2. Bianconi E, Piovesan A, Facchin F, Beraudi A, Casadei R, Frabetti F, Vitale L, Pelleri MC, Tassani S, Piva F (2013) An estimation of the number of cells in the human body. Ann Hum Biol 40(6):463–471

3. Bialvaei AZ, Kouhsari E, Salehi-Abargouei A, Amirmozafari N, Ramazanzadeh R, Ghadimi-Daresajini A, Sedighi M (2017) Epidemiology of multidrug-resistant Acinetobacter baumannii strains in Iran: a systematic review and meta-analysis. J Chemother 29(6):327–337

4. O'Hara AM, Shanahan F (2006) The gut flora as a forgotten organ. EMBO Rep 7(7):688–693

5. Schroeder BO, Bäckhed F (2016) Signals from the gut microbiota to distant organs in physiology and disease. Nat Med 22(10):1079

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Gut Microbiota and Major Depressive Disorder: Current Understanding and Novel Therapeutic Strategies;Current Pharmaceutical Biotechnology;2024-12

2. Machine learning based identification potential feature genes for prediction of drug efficacy in nonalcoholic steatohepatitis animal model;Lipids in Health and Disease;2024-08-24

3. Assessing the Therapeutic Potential of Fecal Microbiota Transplantation in Steatotic Liver Disease: Current Insights and Future Pathways;Current Hepatology Reports;2024-07-29

4. Dynamic changes of gut microbiota in mouse models of metabolic dysfunction‐associated steatohepatitis and its transition to hepatocellular carcinoma;The FASEB Journal;2024-07-05

5. Food for thought: Making the case for food produced via regenerative agriculture in the battle against non-communicable chronic diseases (NCDs);One Health;2024-06